EP Patent

EP2800743A4 — THERAPEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE

Assigned to Agios Pharmaceuticals Inc · Expires 2015-08-26 · 11y expired

What this patent protects

Patent listed against enasidenib-mesylate.

Drugs covered by this patent

enasidenib-mesylate (ENASIDENIB MESYLATE)

Patent Metadata

Patent number: EP2800743A4
Jurisdiction: EP
Classification: —
Expires: 2015-08-26
Drug substance claim: No
Drug product claim: No
Assignee: Agios Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.